It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Objectives: To determine whether serum vitamin D levels wererelated to the prevalence of anxiety and depression among patientswith chronic obstructive pulmonary disease (COPD), as well as theirspirometry parameters, disease severity, and other clinical findings.
Materials and Methods: Ninety-two stable patients withCOPD aged over 18 years with no exacerbations in the previousmonth were included. Symptom severity was assessed using themodified Medical Research Council (mMRC) dyspnea scale andCOPD Assessment Test (CAT) scores. Spirometry tests wereperformed and previous hospitalization histories were recordedto determine ABCD groups of the patients according to theircombined COPD assessments. Their Body mass index, airflowObstruction, Dyspnea and Exercise capacity (BODE) indices werecalculated and the Hospital Anxiety and Depression Scale (HADS)
was administered. Serum vitamin D levels were determined usingimmune electrochemiluminescence.
Results: According to the HADS scores, 16 patients (17.4%) hadthe risk of anxiety and 29 (31.5%) had the risk of depression. Therisk of anxiety differed significantly (P= 0.016 Fischer’s exact test)
between the ABCD groups. Anxiety scores were positively correlatedwith both mMRC (r= 0.315; P= 0.002) and CAT (r= 0.445; P= 0.000)
scores. Similarly, depression scores correlated positively with mMRC(r= 0.249; P= 0.017) and CAT (r= 0.373; P= 0.000) scores. Neitheranxiety nor depression scores were significantly correlated with % ofpredicted FEV1 (p= 0.339, P= 0.671). Serum vitamin D levels wereinversely correlated with anxiety (r= -0.215; P= 0.039) and depression(r= -0.244; P= 0.019) scores. Anxiety scores were positively correlatedwith BODE although not statistically significantly (r= 0.199; P= 0.058).
Conclusion: A negative correlation was revealed betweenserum vitamin D levels and HADS scores, and symptom scoreswere positively correlated to HADS scores, independent of % ofpredicted FEV1.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer